| Adaptive Immunity and the Risk of Autoreactivity in COVID-19 R Moody, K Wilson, KL Flanagan, A Jaworowski, M Plebanski International Journal of Molecular Sciences 22 (16), 8965, 2021 | 49 | 2021 |
| Natural compounds with potential to modulate cancer therapies and self-reactive immune cells R Moody, K Wilson, A Jaworowski, M Plebanski Cancers 12 (3), 673, 2020 | 36 | 2020 |
| Antibodies against Spike protein correlate with broad autoantigen recognition 8 months post SARS-CoV-2 exposure, and anti-calprotectin autoantibodies associated with better … R Moody, S Sonda, F Johnston, KJ Smith, N Stephens, M McPherson, ... Frontiers in Immunology, 4405, 0 | 21 | |
| Predicted B Cell Epitopes Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity R Moody, KL Wilson, JC Boer, JK Holien, KL Flanagan, A Jaworowski, ... Frontiers in Bioinformatics, 31, 2021 | 18 | 2021 |
| Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy R Moody, K Wilson, NC Kampan, OM McNally, TW Jobling, A Jaworowski, ... Cancers 13 (16), 4201, 2021 | 3 | 2021 |
